The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article, by Asiya Kamber Zaidi and Puya Dehgani-Mobaraki

This excerpt links to a long and difficult article from a scientific publication, The Journal of Antibiotics. If you can make it through the article, but you may just want to stop at the abstract or skip to the conclusion. From Asiya Kamber Zaidi and Puya Dehgani-Mobaraki at nature.com:

Abstract

Considering the urgency of the ongoing COVID-19 pandemic, detection of various new mutant strains and future potential re-emergence of novel coronaviruses, repurposing of approved drugs such as Ivermectin could be worthy of attention. This evidence-based review article aims to discuss the mechanism of action of ivermectin against SARS-CoV-2 and summarizing the available literature over the years. A schematic of the key cellular and biomolecular interactions between Ivermectin, host cell, and SARS-CoV-2 in COVID-19 pathogenesis and prevention of complications have been proposed.

Continue reading→

One response to “The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article, by Asiya Kamber Zaidi and Puya Dehgani-Mobaraki

  1. Pingback: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article, by Asiya Kamber Zaidi and Puya Dehgani-Mobaraki | STRAIGHT LINE LOGIC – Additional survival tricks

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.